Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 13,812 | 804 | 7,579 | 3,626 | 4,989 |
| Cost of Goods | 1,722 | 1,327 | 164 | 478 | 660 |
| Gross Profit | 12,090 | 804 | 7,415 | 3,148 | 4,329 |
| Operating Expenses | 24,267 | 24,371 | 24,141 | 25,703 | 26,505 |
| Operating Income | -11,455 | 804 | -16,562 | -22,077 | -21,516 |
| Interest Expense | 2,824 | 2,856 | 2,863 | 2,940 | 3,259 |
| Other Income | 4,499 | 2,856 | 3,949 | 3,677 | 2,317 |
| Pre-tax Income | -9,780 | 804 | -15,476 | -21,340 | -22,458 |
| Net Income Continuous | -9,780 | 804 | -15,476 | -21,340 | -22,458 |
| Net Income | $-9,780 | $804 | $-15,476 | $-21,340 | $-22,458 |
| EPS Basic Total Ops | -0.13 | -0.19 | -0.21 | -0.33 | -0.35 |
| EPS Basic Continuous Ops | -0.13 | -0.19 | -0.22 | -0.33 | -0.35 |
| EPS Diluted Total Ops | -0.13 | -0.19 | -0.21 | -0.33 | -0.35 |
| EPS Diluted Continuous Ops | -0.13 | -0.19 | -0.22 | -0.33 | -0.35 |
| EBITDA(a) | $-8,920 | $-22,119 | $-14,133 | $-19,672 | $-19,050 |